PDL BioPharma (PDLI)
Add to Watchlists Create an AlertPDL BioPharma PE Ratio TTM:
5.629 for May 23, 2013PDL BioPharma Historical PE Ratio TTM Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 23, 2013 | 5.629 |
| May 22, 2013 | 5.568 |
| May 21, 2013 | 5.642 |
| May 20, 2013 | 5.534 |
| May 17, 2013 | 5.541 |
| May 16, 2013 | 5.514 |
| May 15, 2013 | 5.554 |
| May 14, 2013 | 5.527 |
| May 13, 2013 | 5.467 |
| May 10, 2013 | 5.207 |
| May 9, 2013 | 5.318 |
| May 8, 2013 | 5.386 |
| May 7, 2013 | 5.315 |
| May 6, 2013 | 5.325 |
| May 3, 2013 | 5.278 |
| May 2, 2013 | 5.204 |
| May 1, 2013 | 5.116 |
| April 30, 2013 | 5.217 |
| April 29, 2013 | 5.251 |
| April 26, 2013 | 5.190 |
| April 25, 2013 | 5.184 |
| April 24, 2013 | 5.093 |
| April 23, 2013 | 5.157 |
| April 22, 2013 | 5.157 |
| April 19, 2013 | 5.089 |
| April 18, 2013 | 5.042 |
| April 17, 2013 | 5.022 |
| April 16, 2013 | 5.022 |
| April 15, 2013 | 5.015 |
| April 12, 2013 | 5.204 |
| April 11, 2013 | 5.157 |
| April 10, 2013 | 5.123 |
| April 9, 2013 | 4.954 |
| April 8, 2013 | 4.928 |
| April 5, 2013 | 4.907 |
| April 4, 2013 | 4.934 |
| April 3, 2013 | 4.907 |
| April 2, 2013 | 4.981 |
| April 1, 2013 | 4.948 |
| March 28, 2013 | 4.921 |
| March 27, 2013 | 4.874 |
| March 26, 2013 | 4.887 |
| March 25, 2013 | 4.948 |
| March 22, 2013 | 4.914 |
| March 21, 2013 | 4.934 |
| March 20, 2013 | 4.907 |
| March 19, 2013 | 4.887 |
| March 18, 2013 | 4.853 |
| March 15, 2013 | 4.880 |
| March 14, 2013 | 4.874 |
About Price to Earnings Ratio
The price to earnings ratio (PE Ratio) is the measure of the share price relative to the annual net income earned by the firm per share. PE ratio shows current investor demand for a company share. A high PE ratio generally indicates increased demand because investors anticipate earnings growth in the future. The PE ratio has units of years, which can be interpreted as the number of years of earnings to pay back purchase price.
PE ratio is often referred to as the "multiple" because it demonstrates how much an investor is willing to pay for one dollar of earnings. PE Ratios are sometimes calculated using estimations of next year's earnings per share in the denominator. When this happens, it is usually noted.
Learn More
PDLI PE Ratio TTM Benchmarks
| Companies | |
|---|---|
| Biogen Idec | 36.96 |
| Elan | |
| Novartis | 19.07 |
PDLI PE Ratio TTM Rankings
| Overall |
97th percentile 191 of 8006 |
| Sector |
97th percentile 18 of 686 in Healthcare |
| Industry |
97th percentile 7 of 248 in Biotechnology |
PDLI PE Ratio TTM Range, Past 5 Years
| Minimum | 4.483 | Jan 28 2013 |
| Maximum | 103.21 | Nov 13 2008 |
| Average | 11.86 |
